Ozanimod

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 395 publications

S1P receptors in ulcerative colitis: spotlight on Etrasimod.

S1P receptors in ulcerative colitis: spotlight on Etrasimod.

Journal: Expert opinion on pharmacotherapy

Published: October 31, 2026

Ozanimod-associated Macular Edema: Case Report and Literature Review.

Ozanimod-associated Macular Edema: Case Report and Literature Review.

Journal: Retinal cases & brief reports

Published: October 12, 2026

Proportionate and disproportionate reporting of different infectious complications of disease modifying therapy in multiple sclerosis.

Proportionate and disproportionate reporting of different infectious complications of disease modifying therapy in multiple sclerosis.

Journal: Neurological research and practice

Published: July 31, 2026

PANCCO Clinical Practice Guideline Update for the treatment of ulcerative colitis in adults

PANCCO Clinical Practice Guideline Update for the treatment of ulcerative colitis in adults

Journal: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru

Published: July 25, 2026

Ocrelizumab-related organizing pneumonia in multiple sclerosis: insights from a case series and literature review.

Ocrelizumab-related organizing pneumonia in multiple sclerosis: insights from a case series and literature review.

Journal: Journal of neurology

Published: July 15, 2026

Efficacy and Safety of Ozanimod in Ulcerative Colitis: A Real-World Pan-Hellenic Study.

Efficacy and Safety of Ozanimod in Ulcerative Colitis: A Real-World Pan-Hellenic Study.

Journal: Medicina (Kaunas, Lithuania)

Published: July 07, 2026

Ocular safety signals of sphingosine-1-phosphate receptor modulators in postmarketing surveillance.

Ocular safety signals of sphingosine-1-phosphate receptor modulators in postmarketing surveillance.

Journal: Frontiers in pharmacology

Published: June 14, 2026

Effects of sphingosine-1-phosphate receptor modulators on remyelination in multiple sclerosis: evidence from in vitro experiments, animal models and human studies.

Effects of sphingosine-1-phosphate receptor modulators on remyelination in multiple sclerosis: evidence from in vitro experiments, animal models and human studies.

Journal: Frontiers in immunology

Published: May 29, 2026

Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries.

Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries.

Journal: Paediatric drugs

Published: May 26, 2026

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Journal: Journal of Crohn's & colitis

Published: May 20, 2026

Small Molecules as Advanced Therapy for the Treatment of Inflammatory Bowel Disease, Particularly Regarding Ulcerative Colitis.

Small Molecules as Advanced Therapy for the Treatment of Inflammatory Bowel Disease, Particularly Regarding Ulcerative Colitis.

Journal: Internal medicine (Tokyo, Japan)

Published: May 17, 2026

Cardiac arrhythmias associated with S1PRMs: a pharmacovigilance study based on real-world data.

Cardiac arrhythmias associated with S1PRMs: a pharmacovigilance study based on real-world data.

Journal: Frontiers in pharmacology

Published: May 15, 2026

Showing 1-12 of 395

Last Updated: 11/08/2026